Oxygen affinity
Reversible binding and the local pO₂ gradient govern release. Historical HBOC-201 is reported near P50 40 mmHg at 37°C; BHOC-specific characterization is required.
Oxygen availability and metabolic demand change across the transplant journey. The research task is to characterize the carrier and measure whether organ function can be supported under defined conditions.
Hemoglobin binds oxygen reversibly and releases it as local oxygen pressure falls. This inherent molecular behavior is central to the BHOC Transplant research concept; the device and clinical protocol determine how much carrier reaches the tissue.
Reversible binding and the local pO₂ gradient govern release. Historical HBOC-201 is reported near P50 40 mmHg at 37°C; BHOC-specific characterization is required.
Test carrier function during cooling, cold support and gradual rewarming. P50 and release change with temperature, pH and formulation; P50 ≈ 40 is not a constant from 4 to 37°C.
Match carrier concentration and perfusion conditions to each stage. Measure extraction, ATP, lactate, vascular resistance and organ-specific function against controls.
As local pO₂ falls, hemoglobin’s binding equilibrium favors oxygen release. Choose a demand state to see the idea. The dots are a schematic, not a measured BHOC dose or release curve.
Illustrative interface only. No clinical units or claimed response time.
At a lower local pO₂, carrier saturation falls and oxygen can unload. The amount also depends on affinity, dose, flow, pH and temperature.
Track P50/oxygen curves, kinetics, methemoglobin and vascular response at defined temperatures throughout cooling and rewarming.
Measure energy state, viable operating window, organ-specific output and post-transplant recovery against controls.
Different temperature protocols are distinct experimental conditions. A comparison should name the organ model, perfusate, oxygen input and intended endpoint before attributing an effect to the carrier.
| Research setting | Question to characterize | Boundary |
|---|---|---|
| Normothermic machine perfusion | Carrier concentration, oxygen content, extraction and organ metabolism under the chosen protocol. | Evidence is specific to the organ, perfusate and model. |
| Hypothermic oxygenated perfusion | Oxygen supply and tissue response under cold operating conditions. | Do not assume normothermic affinity or release behaviour applies unchanged. |
| Controlled rewarming or sequential perfusion | How carrier function, metabolic demand and measured injury change across the transition. | Temperature, pH and formulation require stage-specific characterization. |
Machine perfusion circulates fluid through a donor organ. Flow, temperature and the composition of that fluid define the conditions in which the organ receives oxygen. Hypothermic machine perfusion (HMP) runs under cold conditions. Hypothermic oxygenated perfusion adds oxygen to a cold circuit. Normothermic machine perfusion (NMP) runs near body temperature.
Comparisons need to state the organ, the perfusate, the way oxygen enters the circuit and when the measurements were taken. A cold study that varies oxygen supply answers a different question from a warm study that varies the oxygen carrier.
Oxygen delivery depends on how much perfusate reaches the organ and how much oxygen that perfusate carries. For one inlet, oxygen delivery is flow multiplied by inlet oxygen content. An organ with more than one inlet requires the delivery through each inlet to be counted.
Oxygen uptake can be estimated from the difference between oxygen entering and leaving the organ when flows and oxygen content are measured at the relevant sites. In the six-hour study by Laing and colleagues, five discarded human livers perfused with historical Hemopure (HBOC-201) were compared with five matched livers perfused with red cells. The researchers measured oxygen extraction alongside flow and lactate clearance. This was an isolated-liver study.
COMPARE assigned one kidney from each eligible donor after circulatory death to oxygenated HMP and the other to standard HMP without supplemental oxygen. The two kidneys went to different recipients. The main comparison was estimated glomerular filtration rate (eGFR) at 12 months in donor pairs with both grafts still functioning.
Of 106 transplanted pairs, 83 contributed to that main comparison. Mean eGFR was 50.5 with oxygenation and 46.7 with standard HMP, in mL/min per 1.73 m². The estimated difference was 3.7, with a 95% confidence interval from -1.0 to 8.4. The primary comparison was statistically inconclusive. Fewer graft failures were observed with oxygenation in a secondary analysis. The trial tested oxygen supply in cold perfusion.
A circuit study can record oxygen delivery, uptake and injury markers. A transplantation study can follow function after implantation. The planned measurement, the time window and the organ determine what can be concluded from each result.
Within Precision Oxygen Therapeutics, BHOC Transplant proposes studying Biological Hemoglobin Oxygen Carrier under defined conditions, with measurements from donor recovery through rewarming and reperfusion. This research addresses organ sustainability by following function at each stage.